ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,051.09
0.00%
Dow Jones
43,828.06
-0.20%
US Dollar vs MXN
20.1189
-0.06%
Brent Oil
74.12
-0.07%
Bitcoin
105,515.68
1.13%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Alligator Bioscience Ab (0RK9) Cotización

Alligator Bioscience Ab

Alligator Bioscience Ab (0RK9)

LSE
23.00
0.00
(0.00%)
Cerrado 15 Diciembre 10:30AM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
23.00
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
5,000
0.00 Rango del Día 0.00
23.00 Rango de 52 semanas 23.00
Capitalización de Mercado [m]
15.133B
Precio Anterior
23.00
Precio de Apertura
-
Hora
5000
@
0.28
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
6,962
Acciones en circulación
657,954,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-60.88
Beneficio por acción (BPA)
-0.38
turnover
59.27M
Beneficio neto
-248.59M

Acerca de Alligator Bioscience Ab

Sector
Noncomml Resh Organizations
Industria
Noncomml Resh Organizations
Sitio web
www.alligatorbioscience.se
Sede
Lund, Swe
Fundado
-
Alligator Bioscience Ab is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker 0RK9. The last closing price for Alligator Bioscience Ab was SEK23. Over the last year, Alligator Bioscience Ab shares have traded in a share price range of SEK 23.00 to SEK 23.00.

Alligator Bioscience Ab currently has 657,954,000 shares in issue. The market capitalisation of Alligator Bioscience Ab is SEK15.13 billion. Alligator Bioscience Ab has a price to earnings ratio (PE ratio) of -60.88.

0RK9 Últimas noticias

Más noticias

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

01 Abril 2022
PR Newswire (US)

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences PR Newswire LUND, Sweden, April 1, 2022 LUND...

01 Abril 2022
PR Newswire (US)

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

23 Marzo 2022
PR Newswire (US)

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg PR Newswire LUND, Sweden, March 23, 2022 LUND, Sweden, March...

23 Marzo 2022
PR Newswire (US)

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

11 Febrero 2022
PR Newswire (US)

Alligator Bioscience AB: Year End report January-December 2021

Alligator Bioscience AB: Year End report January-December 2021 PR Newswire STOCKHOLM, Feb. 11, 2022 STOCKHOLM, Feb. 11, 2022 /PRNewswire/ -- OPTIMIZE-1 Phase II - On Track and Moving...

11 Febrero 2022
PR Newswire (US)

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

01 Febrero 2022
PR Newswire (US)

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer PR Newswire LUND, Sweden, Feb. 1, 2022 LUND, Sweden, Feb. 1, 2022 /PRNewswire/ -- Alligator Bioscience (Nasdaq...

01 Febrero 2022
PR Newswire (US)

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

19 Enero 2022
PR Newswire (US)

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty

Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty PR Newswire LUND, Sweden, Jan. 19, 2022 LUND, Sweden...

19 Enero 2022
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1002323231800623DE
4002323231625423DE
1200232323696223DE
2600232323374023DE
5200232323305623DE
15600232323179923DE
26000232323190323DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PPSProton Motor Power Systems Plc
0.55p
(83.33%)
5.86M
CADCadogan Energy Solutions Plc
4.25p
(77.08%)
14.62M
KZGKazera Global Plc
1.525p
(35.56%)
89.49M
WEBWebis Holdings Plc
0.125p
(19.05%)
4.67M
PETPetrel Resources Plc
1.35p
(17.39%)
1.43M
MILAMila Resources Plc
0.35p
(-30.00%)
33.37M
IPXImpax Asset Management Group Plc
250.00p
(-23.66%)
3.14M
RNEPEcofin U.s. Renewables Infrastructure Trust Plc
26.20p
(-19.88%)
21.5k
PMPPortmeirion Group Plc
174.00p
(-15.12%)
58.93k
ROCKRockfire Resources Plc
0.165p
(-13.16%)
190.11M
NTVONativo Resources Plc
0.0024p
(0.00%)
967.12M
TRPTower Resources Plc
0.027p
(1.89%)
481.24M
VRSVersarien Plc
0.034p
(11.48%)
374.02M
ORCPOracle Power Plc
0.0315p
(-11.27%)
305M
CPXCap-xx Limited
0.145p
(0.00%)
260.82M

Discusión

Ver feed completo
Moonboy1 Moonboy1 4 minutos hace
No matter how high it goes people will be able to buy it for $75,000 or less in a matter of time. It always comes back to its old high every cycle unless all of a sudden this one is different. So no need to panic. I call $150,000 max for this cycles high before it tanks.
BTCUSD
ap17 ap17 4 minutos hace
Big move coming for XRP, BTC took off and you're the only one that called it.🚅🚅💥🏦🏦
XRPUSD
bas2020 bas2020 4 minutos hace
The Seeking Alpha article neglects to mention that external controls have been widely used and accepted in other trials that led to FDA approvals, particularly for rare and hard-to-study conditions.

NWBO’s Phase 3 results demonstrated clinically meaningful and statistically significan
NWBO
Zadie420 Zadie420 4 minutos hace
Sure and I believe you.
NWBO
Fannie Heyyyyy Fannie Heyyyyy 5 minutos hace
Tomorrow marks 5 weeks until inauguration. Wonder when we can expect to hear who the next FHFA director will be?
kittycattttt kittycattttt 5 minutos hace

Flashing $150,000
BTCUSD
Top Penny Top Penny 5 minutos hace
I was very optimistic until he promised no increase in S/S and it continues to grow!
PSRU
Hosai Hosai 6 minutos hace
But in this analogy you are effectively saying the drug works extremely well for lets say 15% of early AD sufferers whom were lucky enough in the trial to have the drug from day 1 rather than starting taking it from 48 weeks. The 10-15% who would have benefited a lot from the drug who started on the
AVXL
TenKay TenKay 6 minutos hace
I did…
HMBL
misterfishman misterfishman 6 minutos hace
Its a football team and they won you make it difficult to be nice to you and I havnt seen cj2 in months she is doing het6own thing as am I understand rocks for brains.
NNRX
Lime Time Lime Time 7 minutos hace
lol. You are pumping bloated OS junk here. They will dilute the remaining AS, then reverse split the commons.

Find stocks like TSNP that are pre-HMBL stage and that is where you will make the most money.

The insiders continue to steal millions of dollars here off the d
HMBL
investisseur101 investisseur101 9 minutos hace
Its my prediction..Trump dont like Griffin.. but the worst ennemy at Ken Griffin is Elon Musk(Tsla short)..Musk will clean all in this garbage...Ken Griffin.. Gary Gensler..I just hope both will be put into jail.
HMBL
3331 3331 9 minutos hace
BIEL: ActiPatch for Painsomnia!
https://www.facebook.com/share/p/1AhFGyNFqC/
YY1000 YY1000 10 minutos hace
FWIW, my derm KOL contacts tell me that based on feedback from other derms at recent conferences Daxi seems to be doing OK. For instance there was an injector conference this weekend in New York, and when asked who was using Daxi in their practice, barely any hands went up last year, but this year a
RVNC
3331 3331 10 minutos hace
BIEL: ActiPatch for Painsomnia!
https://www.facebook.com/share/p/1AhFGyNFqC/
Strategyone Strategyone 10 minutos hace
New Bitcoin all time high..... Where will it be by market open tomorrow?
BTCUSD
JohnnyMakeBucks JohnnyMakeBucks 10 minutos hace
Nice little nugget in the WW emails … paid service… yes 💰 💴 💵 🏦 🚀

SEATTLE SEAHAWKS VS GREEN BAY PACKERS 8:20 pm EST

WW AI picks the PACKERS playing the money line..

Looking for more? Be on the lookout for an invita
IDVV
lakers17 lakers17 11 minutos hace
BTC another record high $106,488.
MartinLutherKing MartinLutherKing 12 minutos hace
$150,000 a share IPO in 2022 to record low $6.75 congrats to all longs congrats to all of management
RNAZ
familyof5 familyof5 12 minutos hace
That post of course as you know was not directed at you. But you seem to be implying, YOU YOURSELF, can see glaring similarities between you and the poster whom the post was intended lol. You obviously without a doubt are many times better informed as to what has, what is, and what most likely will
HMBL
The_Edge The_Edge 13 minutos hace
Great insights..
Much respect for your contributions..
I'm in agreement..

Wondering who this would be and with who's resources..

"having someone sit on the bid for over a year, buying up the converted shares as they happen,"

Best regards
HMBL
chereb19 chereb19 13 minutos hace
Another whopper of a lie. The product simply doesn't exist. Nice try
RDGL
Investor082 Investor082 13 minutos hace
I agree with you. Management has done the damage already and have no reputation in the investment community or amongst peers. Even the UK approval will not do justice for shareholders as they have spewed so many lies like multiple regulatory applications, multiple franchise deals once MAA is cemente
NWBO
EmpressMonk25 EmpressMonk25 14 minutos hace
Hahaha...appropriate!

https://x.com/xMarketNews/status/1868056714949312608?t=2_LWSs5pKcnzWn0o5GrtSw&s=19
HMBL
3331 3331 14 minutos hace
BIEL + DR. OZ + RFK = $$$
BIOELECTRONICS FLAGSHIP PRODUCT - ACTIPATCH - ON DR. OZ:
Dr. Oz devoted a whole program to explaining PEMF Pulsed ElectroMagnetic Field technology - with audience members wearing Actipatches (BIEL's flagship product) - saying it is changing the practice of med

Su Consulta Reciente

LSE
0RK9
Alligator Bioscience Ab
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados